Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical ACRS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 5.00% | |
| BB Squeeze Started | Range Contraction | 5.00% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 7.79% | |
| Boomer Buy Setup | Bullish Swing Setup | 7.79% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 7.79% | |
| Inside Day | Range Contraction | 7.79% | |
| Fell Below 20 DMA | Bearish | 5.99% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Rose Above 10 DMA | 2 days ago | |
| 10 DMA Resistance | 2 days ago | |
| Up 5% | 2 days ago | |
| Rose Above 20 DMA | 2 days ago | |
| 60 Minute Opening Range Breakout | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2020
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.48 |
| 52 Week Low | 0.7 |
| Average Volume | 3,720,066 |
| 200-Day Moving Average | 5.55 |
| 50-Day Moving Average | 14.46 |
| 20-Day Moving Average | 21.97 |
| 10-Day Moving Average | 22.40 |
| Average True Range | 2.13 |
| ADX | 49.63 |
| +DI | 27.23 |
| -DI | 13.01 |
| Chandelier Exit (Long, 3 ATRs ) | 19.08 |
| Chandelier Exit (Short, 3 ATRs ) | 22.46 |
| Upper Bollinger Band | 24.29 |
| Lower Bollinger Band | 19.65 |
| Percent B (%b) | 0.57 |
| BandWidth | 21.12 |
| MACD Line | 1.96 |
| MACD Signal Line | 2.63 |
| MACD Histogram | -0.6703 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.74 | ||||
| Resistance 3 (R3) | 26.54 | 24.85 | 25.99 | ||
| Resistance 2 (R2) | 24.85 | 23.72 | 24.95 | 25.74 | |
| Resistance 1 (R1) | 23.57 | 23.02 | 24.21 | 23.77 | 25.50 |
| Pivot Point | 21.88 | 21.88 | 22.21 | 21.98 | 21.88 |
| Support 1 (S1) | 20.60 | 20.75 | 21.24 | 20.80 | 19.06 |
| Support 2 (S2) | 18.91 | 20.05 | 19.01 | 18.82 | |
| Support 3 (S3) | 17.63 | 18.91 | 18.57 | ||
| Support 4 (S4) | 17.83 |
